Sanofi : The technical configuration is positive
Entry price | Target | Stop-loss | Potential |
---|
€90.81 |
€95 |
€88 |
+4.61% |
---|
Sanofi shares show a positive technical situation which suggests a continuation of the upward dynamic over the medium term.
Summary● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
● The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths● Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
● The group's high margin levels account for strong profits.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Sales forecast by analysts have been recently revised upwards.
● Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.